I don't know about Sorento, but if CYDY (and others) are already releasing data based on non-FDA approved trials, what is the difference in releasing data from an FDA approved trial? Data is data, no? We already have the anecdotal data, it's just a matter of making it more formal with an FDA submission of the same data.